| Authors | Tomokazu Nagakura, Hiroyuki Wakiguchi, Tomohiro Kubota, Tsuyoshi Yamatou, Yuichi Yamasaki, Yukiko Nonaka, Yasuhito Nerome, Harumi Akaike, Tomoko Takezaki, Hiroyuki Imanaka, Yoshifumi Kawano, Syuji Takei |
| Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 44
Issue 4
Pg. 536-538
(04 2017)
ISSN: 0315-162X [Print] Canada |
| PMID | 28604349
(Publication Type: Letter, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Anti-Inflammatory Agents
- Biological Products
- Tumor Necrosis Factor-alpha
- Infliximab
- Adalimumab
- Etanercept
|
| Topics |
- Adalimumab
(therapeutic use)
- Adolescent
- Anti-Inflammatory Agents
(therapeutic use)
- Arthritis
(drug therapy)
- Biological Products
(therapeutic use)
- Child
- Child, Preschool
- Etanercept
(therapeutic use)
- Female
- Humans
- Infliximab
(therapeutic use)
- Male
- Sarcoidosis
- Synovitis
(drug therapy)
- Treatment Outcome
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
- Uveitis
(drug therapy)
- Young Adult
|
